Aclaris Therapeutics, Inc. (ACRS)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 1.2250 |
| Open | 1.2400 |
| Bid | 1.1500 x 200 |
| Ask | 1.1900 x 500 |
| Day's Range | 1.1650 - 1.2600 |
| 52 Week Range | 0.5900 - 11.1200 |
| Volume | |
| Avg. Volume | 1,007,254 |
| Market Cap | 83.38M |
| Beta (5Y Monthly) | 0.24 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.2700 |
| Earnings Date | Aug 05, 2024 - Aug 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 1.84 |
Simply Wall St.Earnings Update: Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Just Reported And Analysts Are Boosting Their Estimates
A week ago, Aclaris Therapeutics, Inc. ( NASDAQ:ACRS ) came out with a strong set of first-quarter numbers that could...
Insider MonkeyAclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript
Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Q1 2024 Earnings Call Transcript May 7, 2024 Aclaris Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.23835, expectations were $-0.28. Aclaris Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day, and thank […]
- Thomson Reuters StreetEvents
Q1 2024 Aclaris Therapeutics Inc Earnings Call
Q1 2024 Aclaris Therapeutics Inc Earnings Call
© 2024 Yahoo. All rights reserved.